PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27624942-1	2016	The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis.	Tricarboxylic Acids	57-75	isocitrate dehydrogenase (NADP(+)) 1	Homo sapiens	131-137	
27624942-1	2016	The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis.	Tricarboxylic Acids	77-80	isocitrate dehydrogenase (NADP(+)) 1	Homo sapiens	131-137	
27624942-7	2016	Our results provide an additional molecular mechanism for the oncogenic activity of mutant IDH1/2 by revealing an unprecedented link between TCA cycle defects and positive modulation of mTOR function downstream of the canonical PI3K/AKT/TSC1-2 pathway.	Tricarboxylic Acids	141-144	isocitrate dehydrogenase (NADP(+)) 1	Homo sapiens	91-97